Short answer
FITLIFE BRANDS, INC. (FTLF) filed its fiscal 2024 10-K annual report with the SEC on Mar 27, 2025. It reported revenue of $64M (+22.3% year over year) and net income of $9M.
- Top risk flagged: Regulatory risk: FDA dietary supplement regulations with no pre-sale product approval, potential safety or efficacy issues affecting product acceptance and liability
FY2024 key financial metrics · XBRL
- Revenue
- $64M
- +22.3% YoY
- Net income
- $9M
- +69.6% YoY
- Operating margin
- 20.3%
- +6.0 pp YoY
- Gross margin
- 43.6%
- +2.9 pp YoY
- EPS (diluted)
- $0.91
- −15.7% YoY
- ROE
- 24.9%
- +5.3 pp YoY
- Operating cash flow
- $10M
- +127.7% YoY
Source: XBRL data from the FITLIFE BRANDS, INC. (FTLF) FY2024 10-K on SEC EDGAR. USD.
FITLIFE BRANDS, INC. FY2024 10-K analysis
AI summary of each section, grounded in the filing text
Business Overview
- Core business: provider of proprietary nutritional supplements and wellness products marketed under multiple brands across sports, weight loss, and general nutrition
- New segment additions: acquired MRC Brands in Feb 2023 and MusclePharm assets in Oct 2023, expanding e-commerce and wholesale distribution
- Strategic shift: launched Metis Nutrition and relaunched Core Active as online-exclusive to expand presence in corporate GNC stores and online
- Quantitative highlights: employee count increased from 37 to 39 full-time; introduced 23 new products in 2024 vs 18 in 2023; distributes to approx. 700 GNC franchises and 1,400 corporate GNC stores
- Noteworthy fact: effected 2-for-1 stock split in February 2025, retroactively adjusting all share and per share data in filing
Management Discussion & Analysis
- Revenue $64.5M, up 22% YoY from $52.7M; growth driven by acquisitions of MRC & MusclePharm, Legacy FitLife down 10% to $25.4M
- Gross margin improved to 43.6% vs 40.7% YoY; gross profit increased 31% to $28.1M from $21.4M
- Best segment: MRC with Q4 gross margin 48.7%, contribution margin 37.1%; worst: Legacy FitLife down 13% in Q4 revenue, margin 39.7%
- Net income $9.0M, up 70% YoY from $5.3M; operating income grew 74% to $13.1M from $7.6M
- No direct cash flow or capital allocation details disclosed; management pursuing ecommerce growth & expanded GNC distribution post-dispute; key risk: wholesale partner declines impacting Legacy segment
Risk Factors
- Regulatory risk: FDA dietary supplement regulations with no pre-sale product approval, potential safety or efficacy issues affecting product acceptance and liability
- Macroeconomic risk: 66% sales dependence on Amazon U.S. Marketplace, changes in Amazon fees or policies could materially impact revenue
- Supply chain risk: Reliance on limited third-party manufacturers who may terminate contracts at will, risking product supply disruptions and inconsistent quality
- Competitive risk: Intense competition from established brands with greater financial resources could force price reductions and higher marketing spend
- Financial risk: High customer concentration with GNC representing 23% of sales and significant accounts receivable, exposure to GNC’s purchase reductions or bankruptcy impacts
Generated from the filing text; verify against the original. How to read a 10-K
Ask about this 10-K
Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.